Which peptides are studied for heart and blood vessel conditions?

Short answer

8 profiles here are grouped under “Heart and blood vessels”: 6 FDA-approved, 1 in clinical trials and 1 not FDA-approved.

Each entry below quotes its profile and links to the full answer there.

FDA-approved 6

In clinical trials 1

Not FDA-approved 1

PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.

Citations

Sources

Coverage and sources →

Numbered markers in the text point here. Each link opens the original public record.

  1. 1
    Drugs@FDA: TANZEUM (albiglutide), application 125431 · original approval April 15, 2014 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 16, 2026

  2. 2
    Bivalirudin for injection, powder, lyophilized, for solution (Sandoz Inc.) · SPL version 5 · published 2026-07-29 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  3. 3
    Drugs@FDA: ANGIOMAX (bivalirudin), NDA 020873 · original approval December 15, 2000 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  4. 4
    TRULICITY (dulaglutide) injection, solution · SPL version 62 · published 2026-08-10 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked September 15, 2026

  5. 5
    Drugs@FDA application BLA125469 · original submission status AP · 2014-09-18 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  6. 6
    Eptifibatide injection (Baxter Healthcare Company) · SPL version 13 · published 2026-05-21 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  7. 7
    Drugs@FDA: INTEGRILIN (eptifibatide), NDA 020718 · original approval May 18, 1998 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  8. 8
    WEGOVY (semaglutide) injection and tablet · SPL version 19 · published 2026-06-30 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  9. 9
    Drugs@FDA application NDA209637 · original submission status AP · 2017-12-05 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  10. 10
    Drugs@FDA application NDA213051 · original submission status AP · 2019-09-20 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  11. 11
    Drugs@FDA application NDA215256 · original submission status AP · 2021-06-04 · dataset 2026-08-13 ↗

    Drugs@FDA via openFDA · Official source · Source checked August 14, 2026

  12. 12
    VASOSTRICT (vasopressin) injection · SPL version 49 · published 2026-05-18 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026

  13. 13
    Drugs@FDA: VASOSTRICT (vasopressin), NDA 204485 · original approval April 17, 2014 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026

  14. 14
    Efpeglenatide substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked November 16, 2026

  15. 15
    ClinicalTrials.gov record NCT07379333 · retained source version 2026-05-13:c599578eaa8d429e0152e13caf981fed9266ac8441a80524f20f68e1f1aaac63 ↗

    ClinicalTrials.gov · Official source · Source checked November 16, 2026

  16. 16
    Certain bulk drug substances for use in compounding that may present significant safety risks ↗

    U.S. Food and Drug Administration · Official source · Source checked November 14, 2026

  17. 17
    Janssen Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 16 New Drug Applications (May 14, 2020) · FR Doc. 2020-10367 ↗

    Federal Register · Official source · Source checked November 15, 2026

  18. 18
    Drugs@FDA: NATRECOR (nesiritide), NDA 020920 · original approval August 10, 2001 ↗

    U.S. Food and Drug Administration · Official source · Source checked November 15, 2026